ALZN · Alzamend Neuro, Inc. · Executive Compensation
$1.68
+0.00 (+0.00%)
At close · Sep 9
Going-concern doubt
— flagged Jul 22, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our independent registered public accounting firm has issued a report on our financial statements for the year ended April 30, 2026, that contains an emphasis of a matter paragraph expressing substantial doubt about our ability to continue as a going concern due to insufficient capital for us to fund our operations.”View the 10-K filed Jul 22, 2026
Market Cap
$8.05M
Shares
4.79M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Stephan S. Jackman | Chief Executive Officer | $468,288 |
| David J. Katzoff | Chief Financial Officer | $150,000 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Stephan S. Jackman | Chief Executive Officer | $443,617 |
| David J. Katzoff | Chief Financial Officer | $150,000 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Stephan S. Jackman | Chief Executive Officer | $2,223,611 |
| David J. Katzoff | Chief Financial Officer | $116,667 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Lien T. Escalona | Former Chief Financial Officer | $1,182,302 |
| Stephan S. Jackman | Chief Executive Officer | $473,125 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Stephan S. Jackman | Chief Executive Officer Lien Escalona ⁽ ⁾ | $225,000 |
| Kenneth S. Cragun | Senior VP of Finance | $100,000 |